COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Phase 2 Study of the Effects of 6R-BH4 on Symptomatic Peripheral Arterial Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00403494
Recruitment Status : Completed
First Posted : November 23, 2006
Last Update Posted : February 13, 2020
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2008
Actual Study Completion Date : January 2009
Certification/Extension First Submitted : February 10, 2020